Search Within

Jason Konner

Formats
  1. Journal Article (83)
  2. Meeting Abstract (69)
  3. Correspondence (2)
  4. Book Section (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (156)
  2. GDMT, Medicine (156)
  3. Gynecologic Medicine Service (156)
  4. Gynecology Disease Management Team (156)
  5. Solid Tumor Oncology Division (156)
  6. Surgery (59)

More Groups

People
  1. Carol Aghajanian (85)
  2. William Tew (60)
  3. Paul Sabbatini (52)
  4. Martee Hensley (49)
  5. Alexia Iasonos (44)
  6. Roisin O'Cearbhaill (43)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (8)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Gynecologic Oncology (31)
  3. International Journal of Gynecological Cancer (14)
  4. Clinical Cancer Research (13)
  5. Annals of Oncology (9)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. Elsevier Inc. (35)
  3. American Association for Cancer Research (15)
  4. Lippincott Williams & Wilkins (15)
  5. Oxford University Press (11)
  6. Springer (6)

More Publishers

Results (156)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer
    Journal Article

    Tanner, E. J.; Black, D. R.; Zivanovic, O.; Kehoe, S. M.; Dao, F.; Konner, J. A.; Barakat, R. R.; Lichtman, S. M.; Levine, D. A.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Germ cell and sex cord stromal tumors: Clinical introduction
    Book Section

    Gardner, G. J.; Konner, J. A.
    In Soslow, R. A.; Tornos, C. (Eds.) Diagnostic Pathology of Ovarian Tumors (2011)

    Fulltext@MSK | Save
  • Gemcitabine for advanced endometrial carcinoma (EMC): A review of the MSKCC experience
    Meeting Abstract

    Grisham, R. N.; Adaniel, C. H.; Hyman, D. M.; Ma, W.; Iasonos, A.; Aghajanian, C.; Konner, J. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • New drugs for ovarian cancer
    Journal Article

    Bell-Mcguinn, K.; Konner, J.; Tew, W.; Spriggs, D. R.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer
    Journal Article

    Konner, J. A.; Grabon, D. M.; Gerst, S. R.; Iasonos, A.; Thaler, H.; Pezzulli, S. D.; Sabbatini, P. J.; Bell-Mcguinn, K. M.; Tew, W. P.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Survival in epithelial ovarian cancer: A multivariate analysis incorporating BRCA mutation status and platinum sensitivity
    Journal Article

    Gallagher, D. J.; Konner, J. A.; Bell-Mcguinn, K. M.; Bhatia, J.; Sabbatini, P.; Aghajanian, C. A.; Offit, K.; Barakat, R. R.; Spriggs, D. R.; Kauff, N. D.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for advanced ovarian cancer
    Meeting Abstract

    Tanner, E. J.; Dao, F.; Zivanovic, O.; Kehoe, S. M.; Black, D. R.; Konner, J. A.; Barakat, R. R.; Lichtman, S. M.; Levine, D. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Self-identification by Jewish religion: Lack of association with overall survival in ovarian cancer at Memorial Sloan-Kettering Cancer Center from 1998 to 2006
    Meeting Abstract

    Konner, J. A.; Iasonos, A.; Sabbatini, P.; Tew, W. P.; Hensley, M. L.; Aghajanian, C.; Kauff, N. D.; Moss, R. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I study of NY-ESO-1 overlapping peptides with or without incomplete Freund's adjuvant and poly-ICLCL vaccination of ovarian cancer patients in second or third clinical remission
    Meeting Abstract

    Diefenbach, C. S. M.; Sabbatini, P.; Hensley, M. L.; Konner, J. A.; Tew, W. P.; Ritter, G.; Jungbluth, A.; Pan, L. S.; Old, L. J.; Gnjatic, S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of farletuzumab (MORAb-003) in combination with weekly paclitaxel in subjects with platinum-resistant or refractory relapsed ovarian cancer
    Meeting Abstract

    Elit, L.; Konner, J. A.; Armstrong, D. K.; Buck, M.; Dean, A.; Finkler, N. J.; Hulstine, A.; Schweizer, C.; Phillips, M.; Weil, S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save